Information for authors

"Swiss Archives of Neurology, Psychiatry and Psychotherapy" is an internationally peer-reviewed journal.

It fosters dialogue between all institutions and professionals involved in psychiatry and psychotherapy, as well as in neurosciences, throughout Switzerland.


Submission of a paper to the "Archives of Neurology, Psychiatry and Psychotherapy" is understood to imply that the data contained there in has not previously been published (except in abstract form) or is being considered for publication elsewhere.

All submissions to the "Archives of Neurology, Psychiatry and Psychotherapy" should conform to the «Uniform Requirements for Manuscripts Submitted to Biomedical Journals».

 

There are no "article processing charges" (APCs) or "page charges"associated with this journal.

Prior to publication, all manuscripts, with the exception of Editorials, Issues and Book Reviews, undergo a single blind peer review, conducted by independent experts in the field.

Contributions may be submitted in English, in German or French.


Editorial policies

Authorship

Authorship credit should be based only on (1) substantial contributions to the conception or design of the work, or acquisition, analysis or interpretation of data for the work; (2) drafting the work or revising it critically for important intellectual content; (3) final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors.

Acquisition of funding, the collection of data, or general supervision of the research group do not, by themselves, justify authorship, nor does the fact of being in sole charge of the clinic or organisational unit in which the article was prepared. Such contributions should be listed as acknowledgements, as well as those of colleagues who provided reagents, discussions and critical input, editorial help, technical services, etc.

Disclosure of financial and non-financial relationships and activities, and conflicts of Interest

When authors submit a manuscript of any type or format they are responsible for disclosing all relationships and activities that might bias or be seen to bias their work. All authors are requested to sign the disclosure form. Disclosure information for each author needs to be part of a disclosure section in the manuscript.

Duplicate submissions

By their signature, the authors also certify that neither this manuscript, nor any other with substantially similar content by one or more of the same authors, has been published or accepted, or is currently being assessed by another journal with a view to publication. Previously published data can be reproduced in exceptional cases, provided that a full disclosure is made and a plausible reason for republication is given.

Plagiarism detection / scientific misconduct

EMH Swiss Medical Publishers Ltd. is a member of CrossCheck, a service offered by CrossRef and powered by iThenticate software. In our online editorial system, all newly submitted manuscripts are automatically compared with the CrossCheck database. Submissions with overlaps to already published articles are carefully checked for plagiarism by the editorial team.

Scientific misconduct includes but is not necessarily limited to data fabrication, data falsification, purposeful failure to disclose relationships and activities, and plagiarism. We take allegations of misconduct very seriously. Problems concerning scientific misconduct are dealed following the guidelines from the Committee on Publication Ethics (COPE), the World Association of Medical Editors (WAME), and the International Committee of Medical Journal Editors (ICMJE).

Obligation to register clinical trials

We require registration of interventional trials in a primary register that participates in WHO’s International Clinical Trial Registry Platform or in ClinicalTrials.gov at or before the time of first patient enrollment as a condition of consideration for publication, in accord with ICMJE recommendations.

Ethics approval of research

We require every article reporting results of prospective research using human subjects or samples, or results of animal research, to include a statement that the study obtained ethical approval, including the name of the ethics committee(s) or institutional review board(s) and the number/ID of the approval(s). Where ethical approval is not required, the manuscript should include a clear statement of this and the reason why.

When reporting research involving human data, authors should indicate in the methods section whether the procedures followed were assessed and approved by a legally qualified ethics review committee (institutional or national) or, if no formal ethics committee is available, were in accordance with the Helsinki Declaration as revised in 2013. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the study. Approval by a responsible review committee does not preclude editors from forming their own judgement whether the conduct of the research was appropriate.

When reporting experiments on animals, authors should indicate in the methods section whether the institutional and national guides for the care and use of laboratory animals were followed.

Protection of patients’ rights to privacy

Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients’ names, initials, or hospital numbers, should not be published in written descriptions, photographs and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should disclose to these patients that the material will be available via the Internet after publication. Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.

Patient consent should be written and archived by the authors and not submitted to the journal. The authors should provide the journal with a written statement that they have received and archived written patient consent. A standard informed consent form may be obtained from the publisher.

Data sharing

Manuscripts that report the results of clinical trials must contain a data sharing statement as described here.

Review process

Prior to publication, all manuscripts, with the exception of Editorials, Issues, Interviews, Letters to the editor and Book reviews, undergo a single blind peer review, conducted by independent experts in the field. During the review process, authors can check the status of their submitted manuscript via the online manuscript submission and review system.

The Editorial Board may decline a paper on the basis of internal review. Authors who believe that their article has been rejected unfairly may submit an appeal via our online submission system or by sending an e-mail to the editorial office.

Editors and reviewers are explicitly requested to report conflicts of interest that could influence their opinion of the manuscript in question, in which case they will be excluded from the reviewing process of this manuscript. When an editor is author or co-author of a manuscript, she or he is excluded from publication decisions and has no insight into the reviewing process of the article in the manuscript management system.

Post-publication discussions

We welcome debate post publication either through letters to the editor or the comment function at the bottom of every article.

If a correction of a published article is needed it is dealed following the ICMJE guidelines.


Article types

Review articles

Reviews should include a summary covering all essential points and a list of references. Reviews should not exceed 8 pages (about 2200 characters per page, with spacing).

Clinical research highlights

In addition to highlighting current knowledge and ­research results (including their own) in a given ­neuropsychiatric field, the ­authors can take the opportunity to briefly describe an ongoing clinical research project taking place in Switzerland for which patients will be recruited. Their paper can thus include an information box briefly summarising the inclusion criteria for patients to participate in the research, the goal and methods of the study, and the contact address of investigators. Articles for this section should not exceed 8 pages (about 2200 characters per page, with spacing).

Minireviews

Minireviews are based on a presentation given at a congress. They should not exceed 2 pages (about 2200 characters per page, including spaces), have a summary, 1-2 figures or tables, a short list of references and 3-5 key points (take-home messages).

Original articles

Original articles should include a summary covering all essential points and a list of references. They should not exceed 12 pages (about 2200 characters per page, with spacing).

Case reports

Manuscripts should not exceed 5 pages (about 2200 characters per page, with spacing), including abstract, key words, references, figure legends, and tables.

First person accounts

First person accounts are intended to share lived experience of mental illness. The author must be known to the editor, but can be published anonymously or by pseudonym at request. Manuscripts may take various forms (essay, testimony, poem, etc.) and should not exceed 5 pages (about 2200 characters per page, with spacing).

Issues 

Issues are a section for opinions or comments on controversial topics.They should not exceed two pages (about 2200 characters per page, with spacing).

Letters to the Editor

Letters should not exceed two pages (about 2200 characters per page, with spacing).

Book reviews

Book reviews should not exceed one page (2200 characters, with spacing).


Preparation of manuscript

Use only standard abbreviations. Avoid abbreviations in the title of the manuscript. The spelled-out abbreviation followed by the abbreviation in parentheses should be used on first mention unless the abbreviation is a standard unit of measurement. Use abbreviations only for items that are used repeatedly in your manuscript.

Always use SI units. Results in other units may be added in parentheses.

Tables and figures should be commented upon in the text and their position marked at the appropriate point.

Tables should be provided with captions, numbered consecutively and each reproduced on a separate page of the manuscript. The editor, on accepting a paper, may recommend that additional tables containing important backup data too extensive to publish be published on the SANP website. In that event an appropriate statement will be added to the text. Submit such tables for consideration with the paper. Lengthy tables should be included only if absolutely necessary; extensive tables and datasets (e.g. sequencing results) may be archived by SANP as supplementary materials and will be linked to the respective article.

Figures should each be submitted with a legend. Captions should be formulated so as to allow the figure to be understood without reference to the text. All abbreviations employed should be explained in the caption if not already included in the list of abbreviations. 

If you have included in your article figures or tables from other publications, you must obtain permission from the publisher to use them before submission of the manuscript: an image that has been published before can be used in SANP only if the copyright holder has given permission. If you are including figures or tables that have been adapted from published papers, then you are also responsible for obtaining the publisher’s permission to adapt them. Please submit a copy of this permission with your article.

References should follow the standards summarised in the NLM’s International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals: Sample References webpage.


Copyright

The open access publication of the articles requires that the copyright in the accepted article is transferred to Swiss Medical Publishers Ltd., Basel, for the duration of the statutory copyright term. The Publishers thereby acquire the right to use the article an unlimited number of times, to adapt it (e.g. for the purpose of abstracts), to translate it, duplicate it, communicate it, make further use of it, publish or distribute it, in any form and via any medium (including the Internet) and to grant free of charge to the author himself, to third parties and to the general public the corresponding rights of use, adaptation etc. (open access publication).


Supplements

For publication of congress abstracts or other scientific contents the SANP supplements offer many advantages. As official special issues of an established journal they are appreciated in the scientific community. Archiving in the publishing house and in libraries ensures long-lasting conservation and availability of publications.

All SANP Supplements are available in full text via the relevant journal’s online archive.

If you are planning a supplement we shall be very happy to assist you.

Submit your manuscript online

Receipt of your paper will be acknowledged by an email containing a reference number, which should be used in all future communications. During the review process, authors can check the status of their submitted manuscript via the online manuscript submission and review system

Submit online

Verpassen Sie keinen Artikel!

close